MedPath

Sbi Alapharma Canada, Inc.

🇨🇦Canada
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

Fluorescence Imaging of Carcinoma During Breast Conserving Surgery

Phase 3
Recruiting
Conditions
Breast Neoplasm Female
Breast Cancer
Interventions
Drug: Placebo
Device: Eagle V1.2 Imaging System
First Posted Date
2021-03-24
Last Posted Date
2023-08-04
Lead Sponsor
SBI ALApharma Canada, Inc.
Target Recruit Count
370
Registration Number
NCT04815083
Locations
🇺🇸

Orlando Health, Inc., Orlando, Florida, United States

🇺🇸

Montefiore Medical Center, Bronx, New York, United States

🇺🇸

Aurora St. Luke's Medical Centre, Milwaukee, Wisconsin, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.